• Weight management and body composition research
• Appetite regulation and satiety signaling studies
• GLP-1 and GIP receptor pathway research
• Metabolic health and insulin sensitivity studies
• Blood glucose regulation research
• Fat mass reduction and energy balance investigations
• Cardiometabolic health research
• Obesity and overweight management studies
• Food intake behavior and hunger hormone research
• Long-term weight maintenance strategies
• Inflammation and metabolic wellness research
• Non-alcoholic fatty liver disease (NAFLD) research
Mechanism of Interest Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been studied for its ability to enhance satiety, reduce food intake, slow gastric emptying, improve insulin response, and support weight reduction through multiple metabolic pathways.
